Advertisement Genetic Technologies signs license agreement with Eurofins - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Genetic Technologies signs license agreement with Eurofins

Genetic Technologies has signed a settlement and license agreement with Eurofins STA Laboratories of Longmont, Colorado, USA.

As per the agreement, Eurofins STA will gain non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology.

The precise commercial terms of the agreement are covered by formal confidentiality provisions and cannot be disclosed, the companies said.

Eurofins STA was a counterparty to the third formal patent assertion suit filed by Genetic Technologies against ten companies in the US District Court for the District of Colorado.